Clinical Trials Conducted in India For GSK, AstraZeneca, J&J Exploited Vulnerable Patients, Says Journalist
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Clinical trials conducted on behalf of multinational drug companies in India exploited impoverished patients, claim researchers at the Center for Studies in Ethics and Rights in Mumbai
You may also be interested in...
India Plans New Clinical Trial Laws
NEW DELHI - India plans to change laws to give the government power to crack down on firms carrying out unethical drug trials as it seeks to become a global hub for clinical testing, according to a health ministry official
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).